The Combination of the mTOR Inhibitor Rapamycin and Protein Kinase C Inhibitors Produces Marked Synergistic Anti-Myeloma Effects.
Year: 2007
Type: article
Source: Blood
Authors: Dror Shalitin, Michael Share, Richard A. Campbell, Jeffrey Steinberg, Eric Sanchez, Joseph Wang, Richard Leuchter, Mingjie Li, Cathy S. Wang, Haiming Chen, James R. Berenson
Institution: Institute for Myeloma & Bone Cancer Research
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2587418931